Joonyoung Park

Title: Joonyoung Park: Innovator in Nanoparticle Formulations

Introduction

Joonyoung Park is a notable inventor based in West Lafayette, Indiana. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on carrier-free nanoparticles.

Latest Patents

Joonyoung Park holds a patent for a formulation of carrier-free nanoparticles designed for anticancer drug delivery. This formulation, which includes nanocrystals crystallized in a medium containing Pluronic F-127 and coated with albumin (Cim-F-Alb), demonstrates excellent circulation stability. The nanoparticles exhibit the smallest size and the most native albumin, leading to favorable cell interaction profiles and enhanced stability compared to the commercial albumin-based formulation, Abraxane. Notably, it maintains comparable cytotoxicity to both Abraxane and solvent-dissolved paclitaxel (PTX).

Career Highlights

Joonyoung Park is affiliated with the Purdue Research Foundation, where he continues to advance his research in nanoparticle technology. His work is pivotal in developing more effective drug delivery systems that can improve patient outcomes in cancer treatment.

Collaborations

He collaborates with esteemed colleagues, including Yoon Yeo and Bo Sun, who contribute to his research endeavors and help drive innovation in the field.

Conclusion

Joonyoung Park's work in developing carrier-free nanoparticles represents a significant advancement in drug delivery systems. His innovative approach has the potential to enhance the effectiveness of cancer treatments, showcasing the importance of research and development in medical technology.